Cargando…

Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats

BACKGROUND/AIMS: Metformin (MET) is a first-line drug for type 2 diabetes mellitus (DM); its effect on new-onset diabetes after transplantation caused by immunosuppressant therapy is unclear. We compared the effects of MET on DM caused by tacrolimus (TAC) or sirolimus (SRL). METHODS: DM was induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Jian, Lim, Sun Woo, Jin, Long, Yu, Ji Hyun, Kim, Hyun Seon, Chung, Byung Ha, Yang, Chul Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339467/ https://www.ncbi.nlm.nih.gov/pubmed/27688296 http://dx.doi.org/10.3904/kjim.2015.394

Ejemplares similares

The effects of addition of coenzyme Q10 to metformin on sirolimus-induced diabetes mellitus
por: Sun, In O, et al.
Publicado: (2019)

Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats
por: Jin, Long, et al.
Publicado: (2014)

Effect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus
por: Lim, Sun Woo, et al.
Publicado: (2016)

Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy
por: Kim, Jin Young, et al.
Publicado: (2012)

The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
por: Quan, Yi, et al.
Publicado: (2020)

Effect of Sirolimus/Metformin Co-Treatment on Hyperglycemia and Cellular Respiration in BALB/c Mice
por: Albawardi, Alia, et al.
Publicado: (2023)

Therapeutic potential of coenzyme Q(10) in mitochondrial dysfunction during tacrolimus-induced beta cell injury
por: Luo, Kang, et al.
Publicado: (2019)

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
por: Joo, Dong Jin, et al.
Publicado: (2014)

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo
por: Mussin, Nadiar, et al.
Publicado: (2017)

Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
por: Klawitter, Jelena, et al.
Publicado: (2014)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

Shen-Kang protects against tacrolimus-induced renal injury
por: Zhang, Long Ye, et al.
Publicado: (2019)

CTLA4-Ig protects tacrolimus-induced oxidative stress via inhibiting the AKT/FOXO3 signaling pathway in rats
por: Jin, Long, et al.
Publicado: (2023)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Ginseng increases Klotho expression by FoxO3-mediated manganese superoxide dismutase in a mouse model of tacrolimus-induced renal injury
por: Lim, Sun Woo, et al.
Publicado: (2019)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats
por: Rubert, Mercedes, et al.
Publicado: (2015)

Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties
por: Luo, Kang, et al.
Publicado: (2019)

Water-soluble coenzyme Q(10) provides better protection than lipid-soluble coenzyme Q(10) in a rat model of chronic tacrolimus nephropathy
por: Cui, Sheng, et al.
Publicado: (2021)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression
por: Doh, Kyoung Chan, et al.
Publicado: (2019)

Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress
por: Lim, Sun Woo, et al.
Publicado: (2017)

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells
por: Traitanon, Opas, et al.
Publicado: (2015)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against Aspergillus Species
por: Schwarz, Patrick, et al.
Publicado: (2020)

Nicotine exacerbates tacrolimus-induced renal injury by programmed cell death
por: Jiang, Yu Ji, et al.
Publicado: (2021)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
por: Kim, Jin Won, et al.
Publicado: (2021)

Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial
por: Kim, Hyung Duk, et al.
Publicado: (2021)

Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
por: Karapirli, Mustafa, et al.
Publicado: (2012)

Clinical Significance of Pre-Transplant Arterial Stiffness and the Impact of Kidney Transplantation on Arterial Stiffness
por: Kim, Hyun Seon, et al.
Publicado: (2015)

Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation
por: Park, Yohan, et al.
Publicado: (2021)

Impact of ABO incompatible kidney transplantation on living donor transplantation
por: Yu, Ji Hyun, et al.
Publicado: (2017)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
por: Chung, Hyun Hee, et al.
Publicado: (2013)

Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy
por: Woo, Ha Na, et al.
Publicado: (2012)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ko4eib9m8ha2ugfonnlernktfj